0001628280-24-025999.txt : 20240531
0001628280-24-025999.hdr.sgml : 20240531
20240531144318
ACCESSION NUMBER: 0001628280-24-025999
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240529
FILED AS OF DATE: 20240531
DATE AS OF CHANGE: 20240531
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Farid Ramy
CENTRAL INDEX KEY: 0001797707
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39083
FILM NUMBER: 241009139
MAIL ADDRESS:
STREET 1: SCHRODINGER, INC.
STREET 2: 120 WEST 45TH STREET, 17TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10036
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Vir Biotechnology, Inc.
CENTRAL INDEX KEY: 0001706431
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 812730369
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1800 OWENS STREET
STREET 2: SUITE 900
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94158
BUSINESS PHONE: 415-906-4324
MAIL ADDRESS:
STREET 1: 1800 OWENS STREET
STREET 2: SUITE 900
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94158
4
1
wk-form4_1717180989.xml
FORM 4
X0508
4
2024-05-29
0
0001706431
Vir Biotechnology, Inc.
VIR
0001797707
Farid Ramy
C/O VIR BIOTECHNOLOGY, INC.
1800 OWENS STREET, SUITE 900
SAN FRANCISCO
CA
94158
1
0
0
0
0
Common Stock
2024-05-29
4
A
0
16000
0
A
16000
D
Stock Option (Right to Buy)
10.10
2024-05-29
4
A
0
16000
0
A
2034-05-28
Common Stock
16000
16000
D
Stock Option (Right to Buy)
10.10
2024-05-29
4
A
0
16000
0
A
2034-05-28
Common Stock
16000
16000
D
1/3 of the shares subject to the stock option vest and become exercisable on May 29, 2025, and the remaining shares vest in 24 equal monthly installments thereafter.
Shares subject to the stock option vest and become exercisable on the earlier of (i) May 29, 2025, or (i) the date of the Company's next annual meeting of stockholders.
/s/ Vanina de Verneuil, Attorney-In-Fact
2024-05-31